Refanno | Evidence-Based Pharma Content Workflow

Refanno centralizes reference evidence, annotation workflows, and creative collaboration so pharmaceutical teams can move faster with audit-ready confidence.

By the Refanno team. Updated .

Refanno platform overview

Refanno is presented as the first content creation and management platform built specifically for pharmaceutical brand teams that need evidence-linked workflow structure from the start.

References, annotations, claims, and creative output are meant to live in the same operating system so teams can move work forward without losing the source context required for review, approval, and future updates.

The homepage establishes the central promise of the product: less spreadsheet-driven process, less repetitive fact-check churn, and more confidence that every content decision can be traced back to supporting evidence.

Why the platform exists

Pharmaceutical content workflows are slow when references, messaging, and approvals are managed in separate tools. Refanno brings those decisions together so teams can build content with stronger continuity between proof, language, and execution.

That foundation makes the rest of the public site more specific: capabilities explain how the workflow works, pricing explains how it is packaged, and team and contact pages explain who is behind the product and how to start a conversation.